The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

New imaging techniques reveal real-time lung function improvements, offering a breakthrough in diagnosing and treating ...

Administering the drug via injection during eosinophilic exacerbations reduced the need for further treatment by 30% compared to traditional steroid tablets like prednisolone. “This could be a ...

While there is no cure, an innovative treatment option is helping some patients with severe COPD or emphysema breathe easier. Endobronchial Valve Therapy (EBV) is a minimally invasive treatment ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary disease (COPD), and ...

"But it’s appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years," she said. Plans for an upgraded NHS app to allow more patients in England ...

The medication segment was the largest in 2022, favored for its cost-effectiveness and common use as a first-line treatment. .Centriacinar Emphysema Growth: The centriacinar segment, primarily linked ...

For decades, the standard treatment for these potentially life ... benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years. In the ...